Valuation Astellas Pharma Inc. OTC Markets

Stocks

Delayed OTC Markets 01:18:44 22/10/2026 HKT			5-day change	1st Jan Change
15.69 ^USD	+1.34%		+9.32%	+18.04%

10-08	Vir Biotechnology's VIR-5500 Gets FDA Fast Track Designation for Prostate Cancer	MT
10-08	Vir Biotechnology, Inc. and Astellas Pharma Inc. Announce FDAFast Track Designation for PSMA-Targeted Pro-XTEN® Dual-Masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	4,465,501	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-1.04%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	4,406,202	3,984,846	3,609,559
Change	-	-6.22%	-13.1%	23.8%	48.4%	-8.14%	-9.56%	-9.42%
P/E	28.5x	34.7x	173x	51x	15.5x	11.4x	12.3x	16x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	2.13x	1.94x	1.84x
PEG	-	-1.8x	-2.1x	0x	0x	0.3x	-1.62x	-0.7x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.88x	2.02x	2.27x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.86x	1.8x	1.83x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.8x	5.63x	5.99x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.66x	8.37x	9.75x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	9.52x	7.25x	6.99x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	10.5%	13.8%	14.3%
Dividend per Share ²	50	60	70	74	78	80.15	83.08	85.31
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.22%	3.34%	3.43%
EPS ²	67.08	54.24	9.51	28.35	162.8	219	202.4	155.9
Distribution rate	74.5%	111%	736%	261%	47.9%	36.6%	41%	54.7%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,371,429	2,209,470	1,970,501
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	759,330	707,826	602,722
EBIT ¹	155,686	133,029	25,518	41,039	382,633	508,953	476,158	370,335
Net income ¹	124,086	98,714	17,045	50,747	291,535	376,921	345,056	262,291
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-59,299	-480,654	-855,942
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,490.50	2,490.50	2,490.50
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,793,014	-	-
Announcement Date	27/4/22	27/4/23	25/4/24	25/4/25	27/4/26	-	-	-

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.99x	13.22x	28x	0.53%	1,144B
JOHNSON & JOHNSON	37.96x	6.39x	17.99x	2.06%	625B
ABBVIE INC.	36.9x	8.47x	17.49x	2.38%	511B
ROCHE HOLDING AG	21.13x	5.1x	12.68x	2.57%	377B
MERCK & CO., INC.	108.1x	6.04x	25.89x	2.3%	366B
NOVARTIS AG	21.5x	5.61x	13.79x	2.85%	291B
ASTRAZENECA PLC	22.06x	4.46x	12.76x	1.98%	262B
AMGEN INC.	27.87x	7.15x	12.8x	2.3%	237B
GILEAD SCIENCES, INC.	-45.73x	7.01x	27.13x	2.11%	194B
Average	29.64x	7.05x	18.73x	2.12%	445.32B
Weighted average by Cap.	35.48x	8.34x	20.49x	1.8%